SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rein Therapeutics discloses failure to meet continued listing rule

Rein Therapeutics said it failed to satisfy a continued listing rule or standard.

RNTX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.